Total Payments
$1.6M
2024 Payments
$23,744
Companies
54
Transactions
1,165
Medicare Patients
4,778
Medicare Billing
$679,291
Payment Breakdown by Category
Other$1.1M (70.8%)
Royalty/License$380,267 (23.9%)
Consulting$35,888 (2.3%)
Food & Beverage$27,041 (1.7%)
Travel$20,035 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $735,000 | 1 | 46.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $388,334 | 117 | 24.4% |
| Royalty or License | $380,267 | 15 | 23.9% |
| Consulting Fee | $35,888 | 18 | 2.3% |
| Food and Beverage | $27,041 | 968 | 1.7% |
| Travel and Lodging | $20,035 | 39 | 1.3% |
| Honoraria | $2,000 | 1 | 0.1% |
| Entertainment | $49.26 | 2 | 0.0% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$1.6M
1,161 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CONMED Corporation | $1.1M | 35 | $0 (2024) |
| Boston Scientific Corporation | $453,839 | 595 | $0 (2024) |
| Micro-tech Endoscopy USA, Inc. | $3,613 | 15 | $0 (2024) |
| ABBVIE INC. | $2,757 | 150 | $0 (2024) |
| GI Supply, Inc. | $2,674 | 3 | $0 (2019) |
| Ambu Inc. | $2,229 | 9 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,159 | 96 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $712.87 | 32 | $0 (2024) |
| Janssen Biotech, Inc. | $658.82 | 40 | $0 (2023) |
| Celgene Corporation | $495.56 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,744 | 160 | Boston Scientific Corporation ($20,343) |
| 2023 | $48,010 | 176 | Boston Scientific Corporation ($45,639) |
| 2022 | $52,148 | 157 | Boston Scientific Corporation ($50,827) |
| 2021 | $31,589 | 118 | BOSTON SCIENTIFIC CORPORATION ($28,114) |
| 2020 | $37,635 | 77 | Boston Scientific Corporation ($29,496) |
| 2019 | $297,188 | 125 | CONMED Corporation ($247,757) |
| 2018 | $242,810 | 180 | CONMED Corporation ($123,156) |
| 2017 | $855,491 | 172 | CONMED Corporation ($736,295) |
All Payment Transactions
1,165 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | Boston Scientific Corporation | SpyGlass (Device) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: SpyGlass_ENDO | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | CONMED Corporation | STONE BALLOONS (Device) | Royalty or License | Cash or cash equivalent | $972.11 | General |
| Category: GENERAL SURGERY | ||||||
| 12/10/2024 | CONMED Corporation | STONE BALLOONS (Device) | Royalty or License | Cash or cash equivalent | $637.24 | General |
| Category: GENERAL SURGERY | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $34.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | Boston Scientific Corporation | SpyGlass (Device) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: SpyGlass_ENDO | ||||||
| 12/05/2024 | Boston Scientific Corporation | SpyGlass (Device) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: SpyGlass_ENDO | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Boston Scientific Corporation | SpyGlass (Device) | Food and Beverage | In-kind items and services | $3.54 | General |
| Category: SpyGlass_ENDO | ||||||
| 11/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: General - Enteral Feeding_ENDO | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Boston Scientific Corporation | Apollo ESG NXT System (Device) | Food and Beverage | In-kind items and services | $40.80 | General |
| Category: Apollo ESG NXT System_ENDO | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/08/2024 | Boston Scientific Corporation | SpyGlass (Device) | Food and Beverage | In-kind items and services | $212.54 | General |
| Category: SpyGlass_ENDO | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: EXALT Model D_ENDO | ||||||
| 10/28/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/25/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: EXALT Model D_ENDO | ||||||
| 10/24/2024 | Boston Scientific Corporation | SpyGlass (Device) | Food and Beverage | In-kind items and services | $47.60 | General |
| Category: SpyGlass_ENDO | ||||||
| 10/24/2024 | Boston Scientific Corporation | SpyGlass (Device) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: SpyGlass_ENDO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 1,227 | 1,803 | $833,095 | $175,340 |
| 2022 | 29 | 1,145 | 1,667 | $782,994 | $168,812 |
| 2021 | 25 | 1,073 | 1,267 | $733,587 | $150,588 |
| 2020 | 32 | 1,333 | 1,706 | $912,448 | $184,552 |
Total Patients
4,778
Total Services
6,443
Medicare Billing
$679,291
Procedure Codes
117
All Medicare Procedures & Services
117 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 71 | 78 | $86,580 | $15,529 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 166 | $36,022 | $14,556 | 40.4% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 34 | 38 | $74,290 | $13,293 | 17.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 39 | 316 | $48,032 | $11,732 | 24.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 51 | 52 | $55,484 | $10,934 | 19.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 115 | 118 | $80,240 | $9,850 | 12.3% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 59 | 59 | $56,345 | $9,455 | 16.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 79 | 79 | $26,228 | $9,018 | 34.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 40 | 173 | $17,300 | $8,312 | 48.0% |
| 43276 | Replacement of stent in pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 17 | 18 | $36,648 | $6,639 | 18.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 100 | $14,600 | $6,393 | 43.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 46 | $18,906 | $6,307 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 89 | $13,172 | $5,756 | 43.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 29 | 29 | $22,562 | $5,198 | 23.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 47 | $9,964 | $4,512 | 45.3% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 33 | 34 | $52,258 | $4,495 | 8.6% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 14 | 14 | $19,642 | $3,868 | 19.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 36 | 36 | $30,492 | $3,565 | 11.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 18 | 18 | $14,058 | $3,349 | 23.8% |
| 43270 | Destruction of polyp or growth of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $16,133 | $2,777 | 17.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $6,688 | $2,417 | 36.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $13,271 | $2,413 | 18.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $6,351 | $2,373 | 37.4% |
| 43262 | Incision of pancreatic outlet using a flexible endoscope | Facility | 2023 | 17 | 17 | $25,653 | $2,025 | 7.9% |
| 43273 | Exam of common bile and/or pancreatic duct using a flexible endoscope | Facility | 2023 | 19 | 19 | $9,595 | $1,806 | 18.8% |
About Dr. Isaac Raijman, MD
Dr. Isaac Raijman, MD is a Gastroenterology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689679557.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Isaac Raijman, MD has received a total of $1.6M in payments from pharmaceutical and medical device companies, with $23,744 received in 2024. These payments were reported across 1,165 transactions from 54 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($735,000).
As a Medicare-enrolled provider, Raijman has provided services to 4,778 Medicare beneficiaries, totaling 6,443 services with total Medicare billing of $679,291. Data is available for 4 years (2020–2023), covering 117 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Houston, TX
- Active Since 06/16/2005
- Last Updated 04/12/2016
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1689679557
Products in Payments
- Stone Balloons (Device) $859,116
- STONE BALLOONS (Device) $256,372
- SPYGLASS (Device) $222,527
- SpyGlass (Device) $70,910
- SPYBITE (Device) $45,251
- SPYGLASS DIRECT VISUALIZATION SYSTEM (Device) $33,047
- Spyglass (Device) $18,066
- THERAPIES (Device) $12,640
- General - Therapies (Device) $6,750
- SpyScope DS (Device) $6,560
- GENERAL - THERAPIES (Device) $3,607
- SPYBITE BIOPSY FORCEPS (Device) $3,567
- GENERAL BILIARY DEVICES (Device) $3,540
- All Products (Device) $3,217
- OTHER- BSC PRODUCT NOT LISTED (Device) $2,700
- GENERAL BILIARY DEVICES (Device) $2,626
- EXALT Model D (Device) $1,333
- RINVOQ (Biological) $819.22
- STELARA (Biological) $718.28
- XIFAXAN (Drug) $697.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Houston
Dr. Bincy Abraham, Md, MD
Gastroenterology — Payments: $1.9M
Gastroenterology $1.9M
Dr. Brooks Cash, Md, MD
Gastroenterology — Payments: $1.3M
Gastroenterology $1.3M
Dr. Mazen Noureddin, M.d, M.D
Gastroenterology — Payments: $786,099
Gastroenterology $786,099
Dr. Jason Hou, M.d, M.D
Gastroenterology — Payments: $372,514
Gastroenterology $372,514
Kalpesh Patel, Md, MD
Gastroenterology — Payments: $313,187
Gastroenterology $313,187
Dr. Nirav Thosani, Md, MD
Gastroenterology — Payments: $251,409
Gastroenterology $251,409